HR

Healthcare Realty Trust is a medical-office-building REIT whose assets are inherently defensive — healthcare demand is non-cyclical and leases are long (single-tenant buildings average an 11.6-year term). But the company has struggled operationally since the Healthcare Trust of America merger, posting GAAP net losses for three straight years (FY2025 net loss of $246M, an improvement from FY2024's $654M loss). For a REIT those losses are largely non-cash — depreciation & amortization was $564M and impairments recur — so funds from operations, not GAAP EPS, is the right lens. (Note the SEC-tagged 'revenue' line of $28.2M reflects only a narrow contract-revenue item, not rental income, so the headline P/S is not meaningful.)

Cash flow is the concern. Operating cash flow of $457M (down 8.9%) only modestly exceeds the $387M of dividends paid, and that dividend was already cut 15.5%. Management explicitly warns it 'cannot assure you that it will be able to continue paying dividends at or above the rates previously paid.' The portfolio is also leasing-cost intensive: leasing commissions rose to $54.8M (7.5% of cash NOI), the company has $161.8M of committed tenant improvements, and rent abatements are climbing — all of which weigh on free cash flow as it works to re-lease and backfill space. The Prospect Medical bankruptcy is cited as an ongoing negative.